Erstad Brian L
College of Pharmacy, The University of Arizona, 1295 N. Martin - Pulido, PO Box 210207, Tucson, AZ 85721, USA.
Ann Pharmacother. 2008 Dec;42(12):1871-81. doi: 10.1345/aph.1L375. Epub 2008 Nov 18.
The intensive care unit (ICU) continues to be a major focus of decentralized pharmacy activities in health systems that care for critically ill patients. This is not surprising, given the need for rapid decision-making involving unstable patients, the large number of powerful medications typically used per patient, the high cost of many drugs used in the ICU and, most importantly, the evidence demonstrating the benefits of having a pharmacist as part of an interdisciplinary team. The purpose of this paper is to highlight important issues to consider when introducing or developing critical care pharmacy services beginning with the establishment of basic services and continuing through practitioner development, guideline/protocol development and implementation, patient safety, residency training, and research.
重症监护病房(ICU)仍然是为重症患者提供护理的卫生系统中分散式药学活动的主要重点。鉴于需要对不稳定患者进行快速决策、每位患者通常使用大量强效药物、ICU中使用的许多药物成本高昂,以及最重要的是,有证据表明药师作为跨学科团队的一员具有益处,这并不奇怪。本文的目的是强调在引入或发展重症监护药学服务时需要考虑的重要问题,从基本服务的确立开始,一直到从业者发展、指南/协议制定与实施、患者安全、住院医师培训和研究。